Prognostic utility of chemotherapy response score (CRS) and CA-125 ELIMination rate constant K (KELIM) in high-grade serous ovarian cancer treated with neoadjuvant platinum-based chemotherapy
Year: 2026
Type: article
Source: Gynecologic Oncology
Institutions: Mayo Clinic, Mayo Clinic Health System
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7155417599
FWCI:
Cites:
Cited by:
Related to:
